Investigation on the Metabolic Regulation, Anti-inflammatory and Antioxidant Effects of Kaempferia Parviflora Extract to Exercise

Investigation on the Metabolic Regulation, Anti-inflammatory and Antioxidant Effects of Kaempferia Parviflora Extract to Exercise - Exercise Kaempferia Parviflora trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048305

Enrollment

Registered

2022-07-08

Start date

2022-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy individuals

Interventions

Human subjects ingest Kaempferia parviflora extract once a day (75mg micromol/capsule/day) for 2 months. Subjects ingest placebo once a day (75mg micromol/capsule/day) for 2 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy individuals

Exclusion criteria

Exclusion criteria: Abnormal findings on resting 12-lead electrocardiogram and/or blood pressure, Cannot limit drinking the day before the experiment, Smoking or taking antioxidant supplements, Taking anti-allergy agent or anti-inflammatory agent

Design outcomes

Primary

Measure	Time frame
Maximal oxygen uptake (2 months after the administration)	—

Secondary

Measure	Time frame
biochemical indices, oxidative stress, inflammatory responses	—

Countries

Japan

Contacts

Public ContactKatsuhiko Suzuki

Waseda University Faculty of Sport Sciences

katsu.suzu@waseda.jp04-2947-6898

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026